President and Chief Operating Officer, Member of the Board of Directors, Precision Biopsy
Precision Biopsy’s President and COO is Adam Savakus, who is an accomplished medical device executive with over 25 years of direct experience driving complex product development, clinical, and regulatory efforts to successful outcomes. He has been a key contributor in the formation, financing and successful execution at several device companies, including the foundation of EndoSonics, a pioneer in the field of Intravascular Ultrasound, which is now an established standard of care in interventional cardiology (IPO, acquired by Jomed, Volcano Therapeutics, Phillips). Adam then joined a 12-person team at Adiana developing a novel transcervical sterilization method, managing the company to a successful 770 patient pivotal trial and FDA PMA Approval (acquired by Cytyc/Hologic). Most recently as EVP at Relievant MedSystems, he successfully led the product development, operations and clinical and regulatory strategy for the Intracept device. Under Adam’s leadership, the company executed a successful randomized, double blinded, Level 1 clinical study for the relief of chronic low back pain—leading to 510(k) approval by the FDA in July 2016. Adam holds a B.S. in Biophysics and a M.S. Bioengineering, both from The Pennsylvania State University.READ MORE
Dr. Priya Werahera, PhD
Chief Scientific Officer, Precision Biopsy
For more than two decades, Precision Biopsy Co-Founder and Chief Scientific Officer Dr. Priya Werahera has been devoted to improving prostate cancer diagnostics and therapies as an Associate Professor in the Departments of Pathology and Bioengineering at the University of Colorado. Among his many clinical research accomplishments include the development of a computer algorithm and methodology that make it possible to use 3D computer models of prostates to demonstrate the efficacy of prostate biopsy protocols, and the initial proof-of-concept work that paved the way for low-risk prostate cancer patients to benefit from targeted focal therapy. Priya holds two BS degrees (University of Moratuwa, Council of Engineering Institute), an MS from Oregon State University and a PhD in Electrical and Computer Engineering from Colorado State University. He has earned several notable patents for his work in tissue classification, published more than 30+ papers in peer-reviewed scientific journals and conference publications and is a senior member of the Institution of Electrical and Electronics Engineers (IEEE).READ MORE
Vice-President, Product Development, Precision Biopsy
John Nichols has been building category-defining products in the medical, telecom and industrial technology sectors for over 35 years. He’s well versed in managing diverse, multi-discipline staffs in executing the product development cycle from phase zero through product launch. Prior to joining Precision Biopsy as Vice President of Product Development, John held leadership positions in both the medical sector (Hach, Tensentric, Plexus GE Medical and Datex-Ohmeda) and the networking and telecommunications sector (Cellport, Aztek Engineering, Lucent Technologies and AT&T Bell Laboratories). He spent his first years as an engineer at Bell Labs, where he earned several patents in telecommunications. John has a BS and MS in Electrical Engineering from the Illinois Institute of Technology and is a member of the Industrial Advisory Board at University of Colorado Boulder and Colorado State University Fort Collins.READ MORE
Vice-President, Clinical Operations, Precision Biopsy
Sierra has over 15 years of experience as a clinical and business leader with expertise in end-to-end clinical trial management in startup, academic, and Fortune 500 environments. Before joining Precision Biopsy, Sierra was the Senior Director of Clinical Operations at Relievant Medsystems, a venture backed company developing a novel therapy for the treatment of chronic low back pain. At Relievant, she led the successful execution of an international 225 patient randomized, double-blind, sham controlled trial to provide level 1 evidence for marketing clearance and support for physician adoption. She has also held increasing clinical trial leadership roles at Adiana (acquired by Hologic) a women’s health care company, where she managed a 770-patient international IDE/PMA to support approval of the company’s transcervical sterilization product. Sierra started her career in industry sponsored clinical trials at Oratec Interventions (acquired by Smith and Nephew) where she worked on various clinical trials to support the company’s portfolio of spine and sports medicine therapies.READ MORE
Chief Executive Officer, Allied Minds
Jill Smith is the CEO of Allied Minds and an Executive Director of the Board. Jill brings more than 25 years of experience as an international business leader, including 16 years as CEO of private and public companies in the technology and information services markets. Most recently, Smith served as Chairman, CEO and President of DigitalGlobe Inc. (NYSE: DGI), a global provider of satellite imagery products and services. Smith started her career as a consultant at Bain & Company, where she rose to become Partner. She subsequently joined Sara Lee as Vice President, and went on to serve as President and CEO of eDial, a VoIP collaboration company, and of SRDS, a business-to-business publishing firm. She also served as Chief Operating Officer of Micron Electronics, and co-founded Treacy & Company, a consulting and boutique investment business.
She currently serves as an independent director on the boards of Endo International plc (NASDAQ: ENDP) and Hexagon (Nasdaq Stockholm: HEXA B).
Omar Amirana, MD
Managing Director, Life Sciences, Allied Minds
Omar Amirana is a Senior Vice President of Allied Minds. Prior to Allied Minds, Omar was a partner in Oxford Bioscience Partners, a Boston-based venture capital firm with $1 billion under management. He has developed and launched products worldwide, and served on the boards of many life science companies, including Flowmedical, SmartPIll, Coherex, Mitralign and Cambridge Endoscopic Devices. Omar is currently on the board of Cardiofocus (AF catheter ablation) as well as the Ignition Awards Committee at Boston University. As a co-founder of Propel Careers, he is passionate about helping aspiring entrepreneurs in life sciences. Omar earned a BS in Mechanical Engineering from Tufts University and an MD from Eastern Virginia Medical School.READ MORE